Patent · US Active

Methods of using soluble heterodimeric cytokine receptor

US7704950B2 · kind B2 · utility

4Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2007
Grant dateApr 27, 2010
Priority date
Expiry dateMar 26, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A soluble receptor that binds to IL-20 having two polypeptide subunits, IL-22R and IL-20RB. The two subunits are preferably linked together. In one embodiment one subunit is fused to the constant region of the light chain of an immunoglobulin, and the other subunit is fused to the constant region of the heavy chain of the immunoglobulin. The light chain and the heavy chain are connected via a disulfide bond.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.